Lista de obras - Salvatore Petta - Dominio Público Uruguay

Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy

scientific article published on 25 September 2019

Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?

artículo científico publicado en 2005

Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe?

scientific article published on 01 April 2012

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

artículo científico publicado en 2013

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women

artículo científico publicado en 2014

Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.

artículo científico publicado en 2013

Cardiovascular diseases and HCV infection: a simple association or more?

artículo científico publicado en 2013

Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

artículo científico publicado en 2012

Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis

artículo científico publicado en 2015

Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2011

Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2013

Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2012

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2014

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

artículo científico publicado en 2013

Current and future HCV therapy: do we still need other anti-HCV drugs?

artículo científico

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

scientific article published on 11 June 2019

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

artículo científico publicado en 2021

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

artículo científico publicado en 2010

Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2012

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

artículo científico publicado en 2012

Epicardial fat in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2015

Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease

artículo científico publicado en 2014

Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease

artículo científico publicado en 2019

Fibrosis evaluation by transient elastography in patients with long-term sustained HCV clearance.

artículo científico publicado en 2013

From current status to optimization of HCV treatment: Recommendations from an expert panel

artículo científico publicado en 2016

Genetic variants in the MTHFR are not associated with fatty liver disease

artículo científico publicado en 2020

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease

artículo científico publicado en 2014

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection

artículo científico publicado en 2011

Hepatitis C and diabetes: the inevitable coincidence?

artículo científico publicado en 2009

Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis

scientific article published on 15 July 2020

High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis

artículo científico publicado en 2011

High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2012

How to optimize HCV therapy in genotype 1 patients: predictors of response.

artículo científico publicado en 2013

Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection

artículo científico publicado en 2012

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2011

IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

artículo científico publicado en 2013

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

artículo científico publicado en 2008

Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: Spectators or actors? ⬇️

artículo científico publicado el 12 de marzo de 2012

Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.

artículo científico publicado en 2017

Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future

artículo científico publicado en 2009

Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis

artículo científico publicado en 2009

Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.

artículo científico publicado en 2009

Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease

artículo científico publicado en 2013

Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients

artículo científico publicado en 2011

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study

artículo científico

Is global elimination of HCV realistic?

artículo científico publicado en 2018

Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.

artículo científico publicado en 2008

Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients

artículo científico publicado en 2012

Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography

artículo científico publicado en 2021

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.

artículo científico publicado en 2010

MAFLD vs NAFLD: Let the contest begin!

scientific article published on 01 September 2020

Metabolic Factors and Chronic Hepatitis C: A Complex Interplay ⬇️

artículo científico publicado el 17 de julio de 2013

Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study

artículo científico publicado en 2017

Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2011

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

article

NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis

artículo científico publicado en 2013

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

artículo científico publicado en 2017

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

artículo científico publicado en 2020

Outcomes of Liver Transplant for Adults With Wilson's Disease

artículo científico publicado en 2020

PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

artículo científico publicado en 2020

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2013

PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.

artículo científico publicado en 2015

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2014

Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study)

artículo científico publicado en 2019

Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population

artículo científico publicado en 2018

Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

artículo científico publicado en 2018

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

article

Reply

Reply to: "Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients".

artículo científico publicado en 2013

Reply to: "is industrial fructose just a marker of an unhealthy dietary pattern?"

artículo científico publicado en 2014

Reply to: “IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients”

artículo científico publicado en 2012

Reply: To PMID 22135089.

artículo científico publicado en 2013

Reply: To PMID 25251399

artículo científico publicado en 2015

Reproductive status is associated with the severity of fibrosis in women with hepatitis C.

artículo científico publicado en 2012

Response to Dr. Sertoglu and Colleagues

scientific article published on 25 August 2014

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

artículo científico publicado en 2008

Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD.

artículo científico publicado en 2017

Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.

artículo científico publicado en 2009

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity

scientific article published on 26 June 2019

Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases

artículo científico publicado en 2012

Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

artículo científico publicado en 2012

Statin use and non-alcoholic steatohepatitis in at risk individuals

artículo científico publicado en 2015

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2014

Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study

artículo científico publicado en 2018

TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2015

The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.

artículo científico publicado en 2014

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2014

The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients

artículo científico publicado en 2015

The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2007

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

article

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

artículo científico publicado en 2015

Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF)

artículo científico publicado en 2014

TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1.

artículo científico publicado en 2011

Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study

artículo científico publicado en 2017

Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.

artículo científico publicado en 2010

Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2011

Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.

artículo científico publicado en 2012

Lista de obras de Salvatore Petta

Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy

Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?

Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe?

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women

Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.

Cardiovascular diseases and HCV infection: a simple association or more?

Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis

Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C.

Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C.

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

Current and future HCV therapy: do we still need other anti-HCV drugs?

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

Epicardial fat in patients with non-alcoholic fatty liver disease

Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease

Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease

Fibrosis evaluation by transient elastography in patients with long-term sustained HCV clearance.

From current status to optimization of HCV treatment: Recommendations from an expert panel

Genetic variants in the MTHFR are not associated with fatty liver disease

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection

Hepatitis C and diabetes: the inevitable coincidence?

Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis

High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis

High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.

How to optimize HCV therapy in genotype 1 patients: predictors of response.

Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: Spectators or actors? ⬇️

Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.

Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future

Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis

Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.

Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease

Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study

Is global elimination of HCV realistic?

Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.

Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients

Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.

MAFLD vs NAFLD: Let the contest begin!

Metabolic Factors and Chronic Hepatitis C: A Complex Interplay ⬇️

Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study

Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C.

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

Outcomes of Liver Transplant for Adults With Wilson's Disease

PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease

PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study)

Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population

Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

Reply

Reply to: "Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients".

Reply to: "is industrial fructose just a marker of an unhealthy dietary pattern?"

Reply to: “IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients”

Reply: To PMID 22135089.

Reply: To PMID 25251399

Reproductive status is associated with the severity of fibrosis in women with hepatitis C.

Response to Dr. Sertoglu and Colleagues

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD.

Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.